Analysis of Prostate Cancer Susceptibility Variants in South African Men: Replicating Associations on Chromosomes 8q24 and 10q11

Prostate Cancer

Volumn 2015, Issue , 2015, Pages

  Fernandez, Pedro ^a   Salie, Muneeb ^b   Du Toit, Danielle ^c   Van Der Merwe, Andre ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c Unistel Medical Laboratories (Pty) Ltd   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGGRESSIVENESS; ARTICLE; CANCER SUSCEPTIBILITY; CHROMOSOME 10Q; CHROMOSOME 8Q; CHROMOSOME VARIANT; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ETHNIC GROUP; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; MALE; POPULATION GROUP; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICAN;

EID: 84961265300     PISSN: 20903111     EISSN: 2090312X     Source Type: Journal    
DOI: 10.1155/2015/465184     Document Type: Article

References (49)

1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, "Global cancer statistics," CA: A Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69-90, 2011.
2. O.W. Brawley, "Trends in prostate cancer in the United States," Journal of the National Cancer Institute-Monographs, vol. 2012, no. 45, pp. 152-156, 2012.
3. J. Ferlay, H.-R. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, "Estimates of worldwide burden of cancer in 2008: GLOBOCAN2008," International Journal of Cancer, vol. 127, no. 12, pp. 2893-2917, 2010.
4. T. R. Rebbeck, S. S. Devesa, B. L. Chang et al., "Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of African descent," Prostate Cancer, vol. 2013, Article ID 560857, 12 pages, 2013.
5. J. Gudmundsson, P. Sulem, A. Manolescu et al., "Genomewide association study identifies a second prostate cancer susceptibility variant at 8q24," Nature Genetics, vol. 39, no. 5, pp. 631-637, 2007.
6. R.A. Eeles, Z. Kote-Jarai, G.G. Giles et al., "Multiplenewly identified loci associated with prostate cancer susceptibility," Nature Genetics, vol. 40, no. 3, pp. 316-321, 2008.
7. R. A. Eeles, Z. Kote-Jarai, A.A. AlOlama et al., "Identificationof seven new prostate cancer susceptibility loci through a genomewide association study," Nature Genetics, vol. 41, no. 10, pp. 1116-1121, 2009.
8. F. R. Schumacher, S. I. Berndt, A. Siddiq et al., "Genome-wide association study identifies new prostate cancer susceptibility loci," Human Molecular Genetics, vol. 20, no. 19, pp. 3867-3875, 2011.
9. R. A. Eeles, A. A. Olama, S. Benlloch et al., "Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array," Nature Genetics, vol. 45, no. 4, pp. 385-392, 2013.
10. P. Gaj, N. Maryan, E. E. Hennig et al., "Pooled sample-based GWAS: a cost-effective alternative for identifying colorectal and prostate cancer risk variants in the Polish population," PLoS ONE, vol. 7, no. 4, Article ID e35307, 2012.
11. E. M. Lange, A. M. Johnson, Y. Wang et al., "Genome-wide association scan for variants associated with early-onset prostate cancer," PloS ONE, vol. 9, no. 4, Article ID e93436, 2014.
12. C. A. Haiman, Y. Han, Y. Feng et al., "Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population," PLoS Genetics, vol. 9, no. 3, Article ID e1003419, 2013.
13. D. Duggan, S. L. Zheng, M. Knowlton et al., "Two genomewide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP," Journal of the National Cancer Institute, vol. 99, no. 24, pp. 1836-1844, 2007.
14. M. B. Cook, Z. Wang, E. D. Yeboah et al., "A genome-wide association study of prostate cancer in West African men," Human Genetics, vol. 133, no. 5, pp. 509-521, 2014.
15. J. Shan, K. Al-Rumaihi, D. Rabah et al., "Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians," Journal of Translational Medicine, vol. 11, no. 1, article 121, 2013.
16. Z. Xu, J. T. Bensen, G. J. Smith, J. L. Mohler, and J. A. Taylor, "GWAS SNP replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP)," The Prostate, vol. 71, no. 8, pp. 881-891, 2011.
17. N. J. Camp, J. M. Farnham, J. Wong, G. B. Christensen, A. Thomas, and L. A. Cannon-Albright, "Replication of the 10q11 and Xp11 prostate cancer susceptibility variants: results from a Utah pedigree-based study," Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 4, pp. 1290-1294, 2009.
18. C. A. Haiman, G. K. Chen, W. J. Blot et al., "Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans," PLoS Genetics, vol. 7, no. 5, Article ID e1001387, 2011.
19. C. Robbins, J. B. Torres, S. Hooker et al., "Confirmation study of prostate cancer susceptibility variants at 8q24 in African Americans identifies a novel susceptibility locus," Genome Research, vol. 17, no. 12, pp. 1717-1722, 2007.
20. C. A. Salinas, E. Kwon, C. S. Carlson et al., "Multiple independent genetic variants in the 8q24 region are associated with prostate cancer risk," Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 5, pp. 1203-1213, 2008.
21. J. Sun, L. Purcell, Z. Gao et al., "Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans," Prostate, vol. 68, no. 7, pp. 691-697, 2008.
22. S. Hooker, W. Hernandez, H. Chen et al., "Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans," Prostate, vol. 70, no. 3, pp. 270-275, 2010.
23. J. Xu, A. S. Kibel, J. J. Hu et al., "Prostate cancer susceptibility associated loci in African Americans," Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 7, pp. 2145-2149, 2009.
24. C. Bonilla, S. Hooker, T. Mason, C. H. Bock, and R. A. Kittles, "Prostate cancer susceptibility loci identified on chromosome 12 in african americans," PLoSONE, vol. 6, no. 2, Article IDe16044, 2011.
25. S. Lindstrom, F. Schumacher, A. Siddiq et al., "Characterizing associations and SNP-environment interactions for GWASidentified prostate cancer risk markers-results from BPC3," PLoS ONE, vol. 6, no. 2, Article ID e17142, 2011.
26. A. B. Murphy, F. Ukoli, V. Freeman et al., "8q24 risk alleles in West African and Caribbean men," Prostate, vol. 72, no. 12, pp. 1366-1373, 2012.
27. Y.-R. Zhang, Y. Xu, M. Liuet al., "Associationof sixsusceptibility loci with prostate cancer in Northern Chinese men," Asian Pacific Journal of Cancer Prevention, vol. 13, no. 12, pp. 6273-6276, 2012.
28. J. Y. Chan, H. Li, O. Singh et al., "8q24 and 17q prostate cancer susceptibility loci in a multiethnic Asian cohort," Urologic Oncology, vol. 31, no. 8, pp. 1553-1560, 2013.
29. E. A. Tindall, M. R. Bornman, S. Van Zyl et al., "Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa," BMC Urology, vol. 13, article 74, 2013.
30. Y. Han, L. B. Signorello, S. S. Strom et al., "Generalizability of established prostate cancer risk variants in men of African ancestry," International Journal of Cancer, vol. 136, no. 5, pp. 1210-1217, 2015.
31. P. Fernandez, C. M. Zeigler-Johnson, E. Spangler et al., "Androgen metabolism gene polymorphisms, associations with prostate cancer risk and pathological characteristics: a comparative analysis between South African and Senegalese men," Prostate Cancer, vol. 2012, Article ID 798634, 8 pages, 2012.
32. P. H. Westfall and S. S. Young, Resampling-Based Multiple Testing, Wiley, New York, NY, USA, 1993.
33. J. J. Chen, P. K. Roberson, and M. J. Schell, "The false discovery rate: a key concept in large-scale genetic studies," Cancer Control, vol. 17, no. 1, pp. 58-62, 2010.
34. H.-Y. Yeh, S.-W. Cheng, Y.-C. Lin, C.-Y. Yeh, S.-F. Lin, and V.- W. Soo, "Identifying significant genetic regulatory networks in theprostate cancer from microarray data based on transcription factor analysis and conditional independency," BMC Medical Genomics, vol. 2, article 70, 2009.
35. D. J. Hazelett, S. K. Rhie, M. Gaddis et al., "Comprehensive functional annotation of 77 prostate cancer risk loci," PLoS Genetics, vol. 10, no. 1, Article IDe1004102, 2014.
36. L.W. Harries, J. R. B. Perry, P. McCullagh, and M. Crundwell, "Alterations in LMTK2, MSMB and HNF1B gene expression are associated with the development of prostate cancer," BMC Cancer, vol. 10, article 315, 2010.
37. L. Yang, C. Lin, C. Jin et al., "lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs," Nature, vol. 500, no. 7464, pp. 598-602, 2013.
38. S. Kastler, L. Honold, M. Luedeke et al., "POU5F1P1, a putative cancer susceptibility gene, is overexpressed in prostatic carcinoma," The Prostate, vol. 70, no. 6, pp. 666-674, 2010.
39. M. M. Pomerantz, Y. Shrestha, R. J. Flavin et al., "Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis," PLoS Genetics, vol. 6, no. 11, Article ID e1001204, 2010.
40. C. Debiais-Delpech, J. Godet, N. Pedretti et al., "Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression," Urologic Oncology: Seminars and Original Investigations, vol. 32, no. 4, pp. 426-432, 2014.
41. A. Fujita, L. R. Gomes, J. R. Sato et al., "Multivariate gene expression analysis reveals functional connectivity changes between normal/tumoral prostates," BMC Systems Biology, vol. 2, article 106, 2008.
42. H.-J. Ni, Y.-N. Chang, P.-H. Kao et al., "Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells," Biochimica et Biophysica Acta-General Subjects, vol. 1820, no. 12, pp. 1893-1900, 2012.
43. M. Brecht, A. C. M. Steenvoorden, S. Luf, C. R. Bartram, and J.W. G. Janssen, "Rearrangement and expression of myeov and hst in NIH/3T3 transfectants: a caveat for the interpretation of DNA transfection analyses," Oncology Reports, vol. 17, no. 5, pp. 1127-1131, 2007.
44. South African National Cancer Registry (NCR) Reports, http://www.nioh.ac.za/assets/files/NCR 2009 FINAL.pdf.
45. M. Daya, L. van der Merwe, P. D. van Helden, M. Möller, and E. G. Hoal, "Therole of ancestry in TB susceptibility of an admixed South African population," Tuberculosis, vol. 94, no. 4, pp. 413-420, 2014.
46. C. R. Ritch, B. F. Morrison, G. Hruby et al., "Pathological outcome and biochemical recurrence-free survival after radical prostatectomy in African-American, Afro-Caribbean (Jamaican) and Caucasian-American men: an international comparison," BJU International, vol. 111, no. 4, pp. E186-E190, 2013.
47. N. Ahmadiyeh, M. M. Pomerantz, C. Grisanzio et al., "8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC," Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 21, pp. 9742-9746, 2010.
48. M. M. Pomerantz, C. A. Beckwith, M.M. Regan et al., "Evaluation of the 8q24 prostate cancer risk locus and MYCexpression," Cancer Research, vol. 69, no. 13, pp. 5568-5574, 2009.
49. C. F. Heyns, S. Mathee, A. Isaacs, A. Kharwa, P. M. De Beer, and M. A. Pretorius, "Problems with prostate specific antigen screening for prostate cancer in the primary healthcare setting in South Africa," BJU International, vol. 91, no. 9, pp. 785-788, 2003.